Teladoc Health Inc. (TDOC) has gone up tremendously the past few years. Prices went sideways for much of 2019 near $50 or so and now it has become a household name and trading around $225. All the doctors I know have adopted it, so I wonder if it has made it to a saturation point.
More from Investing
The memory giant indicated November quarter sales would be below its preliminary outlook, and also says its August quarter will be more back-end loaded than originally expected.
Investors have the opportunity to buy Bristol-Myers Squibb at a fairly low valuation, along with a solid 2.8% dividend yield.
I try hard to not rush to be bearish, but I'm seeing some reasons for caution, and here they are.
Penny stocks are for suckers, and six other rules for better investing -- and tuning out the tweet noise.